Primary LAMP-2 deficiency causes X-linked vacoular cardiomyopathy and myopathy (Danon disease)

被引:627
作者
Nishino I. [1 ,3 ]
Fu J. [2 ]
Tanji K. [1 ]
Yamada T. [4 ]
Shimojo S. [5 ]
Koori T. [6 ]
Mora M. [7 ]
Riggs J.E. [8 ]
Oh S.J. [9 ]
Koga Y. [10 ]
Sue C.M. [1 ]
Yamamoto A. [3 ]
Murakami N. [3 ]
Shanske S. [1 ]
Byrne E. [11 ]
Bonilla E. [1 ]
Honaka I. [3 ]
DiMauro S. [1 ]
Hirano M. [1 ]
机构
[1] Department of Neurology, Columbia University, New York, NY 10032, 630 West 168th Street
[2] Dept. of Genetics and Development, Columbia University, New York, NY 10032, 630 West 168th Street
[3] Dept. of Ultrastructural Research, National Institute of Neuroscience, Natl. Ctr. of Neurol. and Psychiatry, Kodaira, Tokyo 187-8502
[4] Department of Neurology, Kyushu University, Fukuoka 812-8582, 3-1-1 Maidashi, Higashi-ku
[5] Department of Internal Medicine, S. Marianna Univ. School of Medicine, Kawasaki, Kanagawa 216-8512, 2-16-1 Sugao, Miyamae-ku
[6] Department of Pediatrics, Yokohama Rosai Hospital, Yokohama Kanagawa 222-0036, 321 Kozukue-cho, Kouhoku-ku
[7] Department of Neuromuscular Diseases, Natl. Neurol. Institute C. Besta, Milan 20133
[8] Department of Neurology, West Virginia University, Morgantown, WV 26506
[9] Department of Neurology, University of Alabama at Birmingham, UAB Station, Birmingham
[10] Dept. of Pediatrics and Child Health, Kurume University, Kurume, Fukuoka 830-0011
[11] Department of Clinical Neuroscience, St. Vincents Hospital, Fitzroy
关键词
D O I
10.1038/35022604
中图分类号
学科分类号
摘要
'Lysosomal glycogen storage disease with normal acid maltase', which was originally described by Danon et al., is characterized clinically by cardiomyopathy, myopathy and variable mental retardation. The pathological hallmark of the disease is intra-cytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells. Sarcolemmal proteins and basal lamina are associated with the vacuolar membranes. Here we report ten unrelated patients, including one of the patients from the original case report, who have primary deficiencies of LAMP-2, a principal lysosomal membrane protein. From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease4. To our knowledge this is the first example of human cardiopathy-myopathy that is caused by mutations in a lysosomal structural protein rather than an enzymatic protein.
引用
收藏
页码:906 / 910
页数:4
相关论文
共 50 条
  • [41] Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy
    Karolczak, Sophie
    Deshwar, Ashish R.
    Aristegui, Evangelina
    Kamath, Binita M.
    Lawlor, Michael W.
    Andreoletti, Gaia
    Volpatti, Jonathan
    Ellis, Jillian L.
    Yin, Chunyue
    Dowling, James J.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (18)
  • [42] Danon Disease Presenting with Slowly Progressive Cardiomyopathy and Harboring a Novel Missense Variant in the Lysosome-associated Membrane Protein Type 2 (LAMP-2) Gene
    Nakagawa, Yoichiro
    Hayashi, Kenshi
    Tada, Takayasu
    Asakawa, Miwako
    Yoshida, Shohei
    Nomura, Akihiro
    Miwa, Kenji
    Furusho, Hiroshi
    Takamura, Masayuki
    Yasuda, Toshihiko
    INTERNAL MEDICINE, 2025, 64 (06) : 857 - 863
  • [43] Subclinical LAMP-2 Positive Autophagic Vacuolar Myopathy in Two Brothers with Pigmentary Retinopathy, Hypertrophic Cardiomyopathy and Epilepsy
    Cortese, Andrea
    Galimberti, Carlo A.
    Grampa, Giampiero
    Lucchini, Valeria
    Napoli, Laura
    Ciscato, Patrizia
    Sciacco, Monica
    Moggio, Maurizio
    Piccolo, Giovanni
    NEUROLOGY, 2011, 76 (09) : A283 - A283
  • [44] X-LINKED ADRENAL FAILURE, NEURO-MYOPATHY, AND GLYCEROKINASE (GK) DEFICIENCY
    KOHLSCHUTTER, A
    WILLIG, RP
    KRUSE, R
    SCHAFER, H
    NEUROPEDIATRICS, 1985, 16 (03) : 180 - 180
  • [45] Intracranial hemorrhage secondary to vitamin K deficiency in X-linked myotubular myopathy
    Neese, Jeremy M.
    Yum, Sabrina
    Matesanz, Susan
    Raffini, Leslie J.
    Whitworth, Hilary B.
    Loomes, Kathleen M.
    Mayer, Oscar H.
    Alcamo, Alicia M.
    NEUROMUSCULAR DISORDERS, 2021, 31 (07) : 651 - 655
  • [46] Danon disease: A novel mutation in the LAMP-2 gene and ophthalmic abnormality; [Danon-Krankheit: Eine neue Mutation im LAMP2-Gen mit ophthalmologischen Auffälligkeiten]
    He J.
    Wang Y.
    Jiang T.
    Herz, 2014, 39 (7) : 877 - 879
  • [47] Amelioration of X-Linked Related Autophagy Failure in Danon Disease With DNA Methylation Inhibitor
    Ng, Kwong-Man
    Mok, Pamela Y.
    Butler, Amy W.
    Ho, Jenny C. Y.
    Choi, Shing-Wan
    Lee, Yee-Ki
    Lai, Wing-Hon
    Au, Ka-Wing
    Lau, Yee-Man
    Wong, Lai-Yung
    Esteban, Miguel A.
    Siu, Chung-Wah
    Sham, Pak C.
    Colman, Alan
    Tse, Hung-Fat
    CIRCULATION, 2016, 134 (18) : 1373 - +
  • [48] Morphologic and Clinical Aspects of Danon Disease in a Patient with a Mutation c.137G > A in the LAMP-2 Gene
    Fidzianska, Anna
    Madej-Pilarczyk, Agnieszka
    Walczak, Ewa
    Kuch, Marek
    NEUROPEDIATRICS, 2013, 44 (05) : 276 - 280
  • [49] An X-linked dominant mutation in LAMEP2 causing Danon disease associated with myotonia expanding the spectrum
    Chan, S. H. S.
    Kan, A.
    Tse, H. F.
    NEUROMUSCULAR DISORDERS, 2013, 23 (9-10) : 821 - 821
  • [50] X-LINKED ICHTHYOSIS AND X-LINKED PLACENTAL SULFATASE DEFICIENCY - DISEASE ENTITY - HISTOCHEMICAL-OBSERVATIONS
    JOBSIS, AC
    DEGROOT, WP
    TIGGES, AJ
    DEBRUIJN, HWA
    RIJKEN, Y
    MEIJER, AEFH
    MARINKOVICILSEN, A
    AMERICAN JOURNAL OF PATHOLOGY, 1980, 99 (02) : 279 - 289